Cerebral Infarction: Clinical Trials

285 trials for Cerebral Infarction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

129 completed, 64 unknown, 36 recruiting, 22 terminated. 73 Not applicable, 52 Phase 2, 33 Phase 3, 30 Phase 4, 18 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable73Completed 31, Unknown 17, Terminated 8, Not yet recruiting 7, Recruiting 5, Withdrawn 2, Active not recruiting 1, Enrolling by invitation 1, Suspended 1
Phase 252Completed 23, Unknown 12, Terminated 6, Withdrawn 4, Recruiting 3, Not yet recruiting 2, Active not recruiting 1, Suspended 1
Phase 333Completed 15, Unknown 6, Terminated 5, Not yet recruiting 3, Recruiting 3, Withdrawn 1
Phase 430Completed 18, Unknown 7, Recruiting 3, Not yet recruiting 1, Terminated 1
Phase 118Completed 7, Unknown 5, Recruiting 2, Suspended 2, Not yet recruiting 1, Withdrawn 1
Early Phase 12Completed 1, Terminated 1

Follow Cerebral Infarction: new trials by email Literature Review of Cerebral Infarction trials Research Report on Cerebral Infarction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction
Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#), Aspirin Tablet - Cerebral Infarction
Phase 1SuspendedSclnow Biotechnology Co., Ltd.402026-12-312026-04-23
Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period.
Allogeneic umbilical cord mesenchymal stem cell, Aspirin Enteric-coated Tablets & Atorvastatin Calcium - Cerebral Infarction
Phase 1 / Phase 2SuspendedSclnow Biotechnology Co., Ltd.402026-12-312026-04-23
Decompressive Craniectomy After Aneurysmal Subarachnoid Hemorrhage (DECIDE-SAH)
Decompressive craniectomy - Aneurysmal Subarachnoid Hemorrhage
Not yet recruitingUniversity Hospital, Essen100002026-11-012026-10-14
Safely Quenching Complement in Stroke Survivors
Pegcetacoplan Injection [Empaveli] - Acute Ischemic Stroke, Cerebral Infarction
Phase 1Not yet recruitingColumbia University202026-10-012026-04-29
Transcranial Doppler Evaluation After Endovascular Thrombectomy for Acute Ischemic Stroke (PRECISE-TCD)
Transcranial Doppler (TCD) examination - Anterior Cerebral Artery Syndrome, Anterior Cerebral Artery Stroke
Not yet recruitingVirginia Commonwealth University1002026-09-012026-09-14
Effects of Mirror Therapy and Motor Imagery on Upper Limb Motor Functions in Middle Cerebral Artery Stroke
Mirror Therapy, Motor Imagery, Routine Physical Therapy - Stroke
Not applicableRecruitingLahore University of Biological and Applied Sciences362026-08-152026-10-28
Early Identification and Diagnosis of BAD-related Stroke
Multisource clinical-imaging artificial intelligence diagnostic assessment - Branch Atheromatous Disease, Acute Ischemic Stroke
RecruitingPeking Union Medical College Hospital16022026-07-152026-07-09
Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL
Edaravone Dexborneol Sublingual Tablets - CADASIL
Phase 2Not yet recruitingHuashan Hospital602026-07-012026-07-09
Biological Collection of the Rare Diseases of the Brain and Eye Vessels Cohort - 2
Biocollection, Neurological evaluation and Biocollection - CADASIL, Cavernous Angioma
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris6002026-06-302026-06-16
HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)
Tirofiban, dual antiplatelet therapy - Stroke, Acute, Stroke, Ischemic
Phase 3RecruitingWeifang Medical University4582026-06-222026-06-25
Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicenter Randomized Controlled Trial (IVT-ALL-IN)
Intravenous administration, MT alone - Stroke
Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris4862026-06-152026-05-22
Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction(ELASTIC)
Aspirin (Early, 2h), Aspirin (Standard, 24h) - Cerebral Infarction, Thrombolysis
Phase 4Not yet recruitingBeijing Chao Yang Hospital2102026-05-012026-05-08
Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial
2mg Baricitinib, 4mg Baricitinib, Placebo - Acute Ichemic Stroke, Anterior Cerebral Artery Stroke
Phase 2 / Phase 3Not yet recruitingThe First Affiliated Hospital of University of Science and Technology of China7502026-03-172026-03-04
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
Psilocybin (Usona Institute) - Stroke, Chronic Stroke
Phase 1RecruitingJohns Hopkins University202026-02-092026-02-13
CT-Angiography Versus Angiogram as Ancillary Tests in the Determination of Death by Neurologic Criteria
Infarction, Brain
RecruitingRegion Stockholm502026-01-012026-03-17
Roods vs PNF for Upper Limb Function in Acute MCA Stroke
Neuromuscular Electrical Stimulation, Rood's Facilitatory Techniques, Proprioceptive Neuromuscular Facilitation - Stroke, Middle Cerebral Artery Infarction
Not applicableEnrolling by invitationUniversity of Faisalabad282026-01-012026-06-01
Neurogenetic And Hemodynamic Of Migraine Aura And Pfo
Intervention - Migraine With Aura
RecruitingAzienda Usl di Bologna2402025-11-242026-02-11
Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Stroke
Mexidol, Glycine - Ischemic Stroke
Phase 4RecruitingPharmasoft1202025-11-042026-05-13
Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
No intervention - Ischemic Stroke, Atrial Fibrillation
RecruitingInsel Gruppe AG, University Hospital Bern5002025-11-042025-11-20
Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis
Tocilizumab, NaCl 0.9% 100ml - Brain Diseases, Ischemic Stroke
Phase 3Not yet recruitingZhujiang Hospital4862025-10-302025-07-28

Showing 20 of 285. Sign in to see all of them.

Narrower conditions

Stroke (128)  ·  Ischemic Stroke (63)  ·  Brain Ischemia (42)  ·  Cerebrovascular Disorders (41)  ·  Infarction, Middle Cerebral Artery (39)  ·  Brain Infarction (34)  ·  CADASIL (33)  ·  Brain Diseases (27)  ·  Vascular Diseases (26)  ·  Central Nervous System Diseases (23)  ·  Nervous System Diseases (22)  ·  Cardiovascular Diseases (21)  ·  Cerebral Hemorrhage (15)  ·  Ischemia (13)

Broader conditions

Pathological Conditions, Signs and Symptoms (285)  ·  Necrosis (284)  ·  Pathologic Processes (282)  ·  Infarction (281)  ·  Ischemia (272)  ·  Cardiovascular Diseases (264)  ·  Nervous System Diseases (263)  ·  Central Nervous System Diseases (262)  ·  Vascular Diseases (259)  ·  Brain Diseases (258)  ·  Brain Infarction (251)  ·  Cerebrovascular Disorders (244)  ·  Brain Ischemia (243)  ·  Stroke (157)  ·  Intracranial Arterial Diseases (86)

Interventions

Aspirin (19)  ·  Cilostazol (9)  ·  Clopidogrel (8)  ·  Transcranial Direct Current Stimulation (7)  ·  Methods (4)  ·  Tenecteplase (4)  ·  Tissue Plasminogen Activator (4)  ·  Acupuncture Therapy (3)  ·  Injections (3)  ·  Rosuvastatin Calcium (3)  ·  Saline Solution (3)  ·  Sodium Chloride (3)  ·  3-n-butylphthalide (2)  ·  Atorvastatin (2)  ·  Blood Specimen Collection (2)

Sponsors

Assistance Publique - Hôpitaux de Paris (8)  ·  University of British Columbia (5)  ·  Beijing Tiantan Hospital (4)  ·  Bispebjerg Hospital (4)  ·  Mayo Clinic (4)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (4)  ·  Tanabe Pharma Corporation (4)  ·  Asan Medical Center (3)  ·  Children's Hospital of Fudan University (3)  ·  China Medical University Hospital (3)  ·  Federal University of Paraíba (3)  ·  Fondation Hôpital Saint-Joseph (3)  ·  Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (3)  ·  Korea Otsuka Pharmaceutical Co., Ltd. (3)  ·  ReNeuron Limited (3)

Countries

China (67)  ·  United States (37)  ·  France (29)  ·  South Korea (20)  ·  Germany (11)  ·  Canada (10)  ·  United Kingdom (10)  ·  Japan (9)  ·  Spain (9)  ·  Denmark (7)  ·  Taiwan (7)  ·  Italy (6)  ·  Brazil (5)  ·  Switzerland (5)  ·  Sweden (4)

Top investigators

Ada Tang, PhD (2)  ·  Adeline Vanderver, MD (2)  ·  Alon Friedman, MD/PhD (2)  ·  Brodie Sakakibara, PhD (2)  ·  Debbie A Hebert, MSc(Kin) (2)  ·  Janice Eng, PhD (2)  ·  Jeffrey Weiss, MD (2)  ·  Mark Bayley, MD (2)  ·  Shinichiro Uchiyama, MD (2)  ·  Steven Levy, MD (2)  ·  Xiaoyun Liu, Prf. (2)  ·  Xin Huang (2)  ·  Aarti Sarwal (1)

Results publications

PMID 22163120, PMID 22068990, PMID 33175411, PMID 37652700, PMID 41508158, PMID 10356105, PMID 10499938, PMID 10811152, PMID 11944746, PMID 15035006, PMID 15364702, PMID 15370761, PMID 15837243, PMID 15843671, PMID 16282547, PMID 16282564, PMID 16336965, PMID 16386660, PMID 16433905, PMID 16490835, PMID 16763187, PMID 17494672, PMID 17622759, PMID 17916121, PMID 17939776, PMID 18029233, PMID 18388340, PMID 18456558, PMID 18462283, PMID 18468545, PMID 19321945, PMID 19430275, PMID 19570514, PMID 19673813, PMID 19727657, PMID 19829090, PMID 19834012, PMID 19900934, PMID 19933977, PMID 20075341, PMID 20386637, PMID 20456839, PMID 20505173, PMID 20833591, PMID 20876500, PMID 20937873, PMID 20947374, PMID 20966420, PMID 21030700, PMID 21150884

NIH funding

1RF1AG074608-01 (1), 2009 (1), 2015 (1), 2019 (1), P50NS044148 (1), P50NS044227 (1), R01AG057855 (1), R01DC008796 (1), R01NS038384 (1), U01NS056256 (1), U01NS092076 (1), U01NS106845 (1), U10NS086487 (1), U54NS115052 (1)